Pharmaceuticals Bayer: Science For A Better Life

You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it.

Benefits and risks of drugs

Benefits and risks of drugs
green

Innovation + Partnering

Finding new options for patients with heart and blood conditions
orange

Innovation + Partnering

The future of cancer therapy is now
orange

Treatment + Care

Cancer is 100 diseases and each patient is unique
blue

Treatment + Care

What you need to know about cancer genomics
blue

Innovation + Partnering

From molecules to medicine
Drug development: The R&D journey
orange
Healthy aging

Healthy aging
green
Health policy

Health policy
green

Innovation + Partnering

Why we partner
orange

Argentina

Chagas Disease

“We believe Chagas is a children’s disease”, Dr Jaime Altcheh says, formulating an altogether radical theory about one of the greatest scourges to afflict Latin America.
Social Channels

FaCEBOOK·2 weeks

No child’s dreams should be put on hold because of cancer. As #ChildhoodCancerAwarenessMonth concludes we are inspired to help shape a future steeped in collaboration with patients and advocates to ensure reliable access to genomic testing and precision treatments. Learn more about our precision medicine efforts: https://bit.ly/2quiTOG, and support childhood cancer patients in their fight: www.stbaldricks.org/support

twitter·2 days

#Precisiononcology can help improve patient outcomes, but #healthpolicy changes & industry-wide collaboration are c…

youtube·3 months

Fish Soup | Easy Healthy Recipes #10

Visit us on Facebook
Visit us on Twitter
Visit us on YouTube
Bayer sponsored clinical studies

Treatment + Care

Bayer trial finder

www.clinicaltrials.gov

Clinicaltrials.gov

www.clinicalstudydatarequest.com

Data sharing portal

Latest press release

Find us in your country

News

2018-09-21

Bayer’s Jivi® approved in Japan for hemophilia A

2018-09-05

Bayer completes biggest acquisition in its history

2018-08-30

Bayer receives US approval for modern hemophilia A treatment Jivi® with a step-wise prophylaxis dosing regimen

2018-08-27

Results of COMMANDER HF and MARINER studies with rivaroxaban published

2018-08-24

Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease
Press center